Hiba Khan

Dr. Hiba Khan is an Academic Assistant Professor in the Division of Hematology and Oncology at the University of Washington School of Medicine and an Assistant Professor in the Clinical Research Division at the Fred Hutchinson Cancer Center. She is based at the Fred Hutchinson Cancer Center at South Lake Union in Seattle, Washington.

Education and Training:

• M.D. from University of Arizona College of Medicine
• M.P.H. from University of Arizona College of Public Health
• Residency in Internal Medicine at University of Washington
• Fellowship in Hematology and Oncology at University of Washington
• Board Certified in Internal Medicine by the American Board of Internal Medicine

Dr. Khan is a medical oncologist specializing in the treatment of genitourinary malignancies, including prostate, bladder, and testicular cancers. As part of the genitourinary cancer research team at Fred Hutch, she actively enrolls patients in clinical trials. Her research focuses on the health economics of cancer care as a member of the Hutchinson Institute for Cancer Outcomes Research, where she studies ways to improve the affordability, accessibility, and quality of cancer care delivery. Her work is driven by patient experiences to make the healthcare system better for cancer patients.

Dr. Khan's recent publications demonstrate a strong focus on prostate cancer research, financial toxicity in cancer care, and health disparities. Her work spans from clinical trials investigating novel treatment approaches for metastatic prostate cancer to analyses of healthcare economics and patient-centered outcomes. She has published in high-impact oncology journals including Journal of Clinical Oncology and European Urology Oncology.

Professional Affiliations:

• Fred Hutchinson Cancer Center
• University of Washington
• Hutchinson Institute for Cancer Outcomes Research

Dr. Khan actively participates in clinical research and patient care, with a particular emphasis on improving cancer care systems through economic analysis and patient-centered approaches. Her work bridges clinical oncology practice with healthcare policy research to address critical challenges in cancer care delivery.